SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-063716
Filing Date
2015-11-09
Accepted
2015-11-09 16:01:58
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v422880_10q.htm 10-Q 547609
2 EXHIBIT 31.1 v422880_ex31-1.htm EX-31.1 11352
3 EXHIBIT 31.2 v422880_ex31-2.htm EX-31.2 11470
4 EXHIBIT 32.1 v422880_ex32-1.htm EX-32.1 4036
5 EXHIBIT 32.2 v422880_ex32-2.htm EX-32.2 3813
  Complete submission text file 0001144204-15-063716.txt   3713735

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tgtx-20150930.xml EX-101.INS 674052
7 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20150930.xsd EX-101.SCH 47275
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20150930_cal.xml EX-101.CAL 36865
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20150930_def.xml EX-101.DEF 242497
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20150930_lab.xml EX-101.LAB 331768
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20150930_pre.xml EX-101.PRE 278244
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 151215537
SIC: 2834 Pharmaceutical Preparations